P David Southwell

Affiliations

  • at Rocket Pharmaceuticals Inc. (RCKT), 2024-06-20
  • at Ptc Therapeutics Inc. (PTCT), 2024-05-10
  • Chief Executive Officer at Tscan Therapeutics Inc. (TCRX), 2023-02-06
  • Director at Spero Therapeutics Inc. (SPRO), 2018-06-07
  • Chief Financial Officer at Human Genome Sciences Inc (HGSI), 2012-08-01
  • Director at Thl Credit Inc. (TCRD), 2010-12-07
  • Director at Biosphere Medical Inc (BSMD), 2010-09-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TCRX $3.55 10,000 Officer, Director 171,569 2022-05-18 Filing
TCRX $3.62 15,000 Officer, Director 161,569 2022-05-18 Filing
TCRX $8.73 11,000 Officer, Director 97,899 2021-09-08 Filing
ITEK $1.75 60,000 Officer, Director 62,765 2017-01-06 Filing
TCRD $13.00 10,200 Director 38,500 2010-12-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RCKT $24.05 10,000 114,784 2024-04-15 Filing
RCKT $25.16 10,284 95,160 2024-04-12 Filing
RCKT $24.22 59,716 105,444 2024-04-12 Filing
PTCT $51.43 5,188 10,500 2023-04-17 Filing
PTCT $50.69 6,241 15,688 2023-04-17 Filing